Trial Details

TERMINATED
Basic Information
Clinical ID c1031
Identifier NCT03802214
Trial Title Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF锛圱umor Necrosis Factor锛塗herapy
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Vedolizumab
Participant Information
Sponsor Stanford University
City Stanford
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2020-10-29
Primary Completion Date 2020-12-11
Completion Date 2020-12-11